GlobalDeal

Glycomimetics

Pharmaceuticals · Rockville, United States

glycomimetics.com

About Glycomimetics

Glycomimetics, Inc. is a biotechnology company focused on the discovery and development of novel glycomimetic drugs for the treatment of cancer and other diseases. The company specializes in leveraging its proprietary glycomimetic technology to create therapeutics that target specific carbohydrate-protein interactions, which play a crucial role in various biological processes. Glycomimetics aims to address unmet medical needs by developing innovative treatments that can improve patient outcomes. The company's lead product candidate, uproleselan, is designed to enhance the efficacy of existing therapies for patients with acute myeloid leukemia (AML) and other hematological malignancies. Glycomimetics is committed to advancing its pipeline through rigorous research and clinical trials, collaborating with academic institutions and industry partners to bring its therapies to market.

Company facts

Industry
Pharmaceuticals
Sub-industries
Biotechnology, Drug Development, Cancer Therapeutics, Glycomimetics, Clinical Research
Location
Rockville, United States
Employees
11–50
Revenue (USD)
1–5M
Founded
2003

Products and services

Open Glycomimetics in GlobalDeal Is this your company? Update the details for free

More Pharmaceuticals companies in United States

All 12,119 Pharmaceuticals companies in United States →